<DOC>
	<DOCNO>NCT01728922</DOCNO>
	<brief_summary>The primary purpose study ass immune response vitamin D supplementation two dos ( 5,000 IU 10,000 IU daily ) healthy control patient clinically isolate syndrome compare placebo . Secondary endpoint include ( 1 ) disease outcome clinically isolated syndrome term clinical relapse evidence new lesion MRI ( McDonald 's MS ) , 2 ) Safety dos use</brief_summary>
	<brief_title>Dose-related Effects Vitamin D3 Immune Responses Patients With Clinically Isolated Syndrome</brief_title>
	<detailed_description>Primary endpoint : To determine effect vitamin D supplementation two dos ) 5,000 IU daily b ) 10,000 IU daily compare c ) placebo 24 week period change baseline frequency CD4 T cell subset cytokine response peripheral blood mononuclear cell 1 ) patient clinically isolated syndrome . 2 ) healthy control participant . Secondary endpoint : 1 . To determine whether dose response effect supplementation use 5,000 IU 10,000 IU vitamin D versus placebo 24 week change baseline frequency CD4 T cell subset cytokine response PBMC 1 ) patient clinically isolated syndrome ( CIS ) 2 ) healthy control participants 2 . To establish whether clinical response vitamin D measure ) change number T2 lesion Gadolinium enhance lesion MRI scan 24 week compare baseline b ) reduction relapse 24 week treat ( 5,000 IU 10,000 IU ) CIS patient versus CIS patient receive placebo .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>To eligible inclusion , subject must meet follow criterion Screening ( Visit 1 ) must continue fulfil criterion Baseline ( Visit 2 ) . CIS : Patients clinically isolated syndrome onset relapse within previous three month two two asymptomatic T2 lesion MRI brain scan . Aged 1855yrs . Not receive disease modify therapy . Patients disease demyelination could explain sign symptom . Participants know disease parathyroid , history vitamin D intolerance , sarcoidosis , history hypercalcaemia cause . Participants baseline abnormality serum urea , creatinine , calcium , parathormone . Participants thiazide diuretic ( hypercalcaemia risk ) . Patients occurrence relapse le six week prior entry study . Previous treatment betainterferons glatiramer acetate steroid last three month . Any previous treatment mitoxantrone immunosuppressant . Participants already take supplemental vitamin D .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Clinically isolated syndrome</keyword>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Immune response</keyword>
	<keyword>CD4 T cell subset</keyword>
	<keyword>Cytokine</keyword>
</DOC>